Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gαq-coupled protein receptors

被引:136
作者
Bhatnagar, A
Sheffler, DJ
Kroeze, WK
Compton-Toth, B
Roth, BL
机构
[1] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA
关键词
D O I
10.1074/jbc.M404673200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Hydroxytryptamine 2A (5-HT2A) serotonin receptors are important for a variety of functions including vascular smooth muscle contraction, platelet aggregation, and the modulation of perception, cognition, and emotion. In a search for 5-HT2A receptor-interacting proteins, we discovered that caveolin-1 (Cav-1), a scaffolding protein enriched in caveolae, complexes with 5-HT2A receptors in a number of cell types including C6 glioma cells, transfected HEK-293 cells, and rat brain synaptic membrane preparations. To address the functional significance of this interaction, we performed RNA interference-mediated knockdown of Cav-1 in C6 glioma cells, a cell type that endogenously expresses both 5-HT2A receptors and Cav-1. We discovered that the in vitro knockdown of Cav-1 in C6 glioma cells nearly abolished 5-HT2A receptor-mediated signal transduction as measured by calcium flux assays. RNA interference-mediated knockdown of Cav-1 also greatly attenuated endogenous Galpha(q)-coupled P2Y purinergic receptor-mediated signaling without altering the signaling of PAR-1 thrombin receptors. Cav-1 appeared to modulate 5-HT2A signaling by facilitating the interaction of 5-HT2A receptors with Galpha(q). These studies provide compelling evidence for a prominent role of Cav-1 in regulating the functional activity of not only 5-HT2A serotonin receptors but also selected Galpha(q)-coupled receptors.
引用
收藏
页码:34614 / 34623
页数:10
相关论文
共 45 条
  • [31] CAVEOLIN, A PROTEIN-COMPONENT OF CAVEOLAE MEMBRANE COATS
    ROTHBERG, KG
    HEUSER, JE
    DONZELL, WC
    YING, YS
    GLENNEY, JR
    ANDERSON, RGW
    [J]. CELL, 1992, 68 (04) : 673 - 682
  • [32] In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates
    Rothman, RB
    Vu, N
    Partilla, JS
    Roth, BL
    Hufeisen, SJ
    Compton-Toth, BA
    Birkes, J
    Young, R
    Glennon, RA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01) : 138 - 145
  • [33] Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae -: A mechanism to functionally regulate the cAMP signaling pathway
    Rybin, VO
    Xu, XH
    Lisanti, MP
    Steinberg, SF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) : 41447 - 41457
  • [34] Saucier C, 1997, J NEUROCHEM, V68, P1998
  • [35] Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice - Treatment with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice
    Schubert, W
    Frank, PG
    Woodman, SE
    Hyogo, H
    Cohen, DE
    Chow, CW
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 40091 - 40098
  • [36] Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo
    Schubert, W
    Frank, PG
    Razani, B
    Park, DS
    Chow, CW
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) : 48619 - 48622
  • [37] Schwencke C, 1999, J CELL BIOCHEM, V75, P64, DOI 10.1002/(SICI)1097-4644(19991001)75:1<64::AID-JCB7>3.3.CO
  • [38] 2-C
  • [39] 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro
    Setola, V
    Hufeisen, SJ
    Grande-Allen, KJ
    Vesely, I
    Glennon, RA
    Blough, B
    Rothman, RB
    Roth, BL
    [J]. MOLECULAR PHARMACOLOGY, 2003, 63 (06) : 1223 - 1229
  • [40] Salvinorin A: the 'magic mint' hallucinogen finds a molecular target in the kappa opioid receptor
    Sheffler, DJ
    Roth, BL
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (03) : 107 - 109